Billing and Coding: Dexamethasone Intracanalicular Ophthalmic Insert (Dextenza®)

This billing and coding policy (A58392) provides guidelines that complement Local Coverage Determination L38792 for Dexamethasone Intracanalicular Ophthalmic Insert (Dextenza®). Specific coverage indications, limitations, frequency limits, and medical necessity criteria are defined in LCD L38792 and must be consulted for claim adjudication.

"Billing, coding, and other guidelines for Dexamethasone Intracanalicular Ophthalmic Insert (Dextenza®) must follow and complement Local Coverage Determination L38792."

Sign up to see full coverage criteria, indications, and limitations.